These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3582394)
1. Value of effort testing and acute drug testing in the evaluation of antiarrhythmic treatment. Bayés de Luna A; Guindo J; Torner P; Borja J; Caturla MC; García S; Dominguez JM; Oter R; Jané F Eur Heart J; 1987 Mar; 8 Suppl A():77-82. PubMed ID: 3582394 [No Abstract] [Full Text] [Related]
2. Utilization of ambulatory electrocardiographic monitoring and exercise stress testing to assess antiarrhythmic drug efficacy. Graboys TB Cardiologia; 1983 Sep; 28(9):803-10. PubMed ID: 6687334 [No Abstract] [Full Text] [Related]
3. Update on new antiarrhythmic drugs. Morton PG Crit Care Nurs Clin North Am; 1994 Mar; 6(1):69-83. PubMed ID: 8192885 [TBL] [Abstract][Full Text] [Related]
4. Exercise stress testing in the management of cardiac rhythm disorders. Podrid PJ; Graboys TB Med Clin North Am; 1984 Sep; 68(5):1139-52. PubMed ID: 6492932 [TBL] [Abstract][Full Text] [Related]
5. Exercise stress testing for exposure of cardiac arrhythmia. Jelinek MV; Lown B Prog Cardiovasc Dis; 1974; 16(5):497-522. PubMed ID: 4590953 [No Abstract] [Full Text] [Related]
6. A class III antiarrhythmic agent. Pelter MM; Adams MG Am J Crit Care; 2002 Jul; 11(4):395-6. PubMed ID: 12102441 [No Abstract] [Full Text] [Related]
8. Spontaneous variability and detection of repetitive extrasystoles during simulated acute antiarrhythmic testing. Hernández-Acosta K; Groning E; Rodríguez-Bereao C; Hernández-Cañero A; García-Barreto D Cor Vasa; 1985; 27(4):287-92. PubMed ID: 2414060 [TBL] [Abstract][Full Text] [Related]
9. Ambulatory cardiac monitoring for the evaluation of antiarrhythmic agents. Antczak-Bouckoms A; Tulloch JF; Adams ME Int J Technol Assess Health Care; 1993; 9(1):124-38. PubMed ID: 8423111 [TBL] [Abstract][Full Text] [Related]
10. Evaluation and treatment of ventricular arrhythmias: an update. McCollam PL; Parker RB Clin Pharm; 1991 Mar; 10(3):195-205. PubMed ID: 2040126 [TBL] [Abstract][Full Text] [Related]
11. Rational use of antiarrhythmic drugs alone and in combination. Bigger JT; Giardina EG Cardiovasc Clin; 1974; 6(2):103-17. PubMed ID: 4613454 [No Abstract] [Full Text] [Related]
12. Newer antiarrhythmic drugs. Schmidt SB; Morgan DZ; Jain AC W V Med J; 1986 Nov; 82(11):433-5. PubMed ID: 3466475 [No Abstract] [Full Text] [Related]
13. [Ventricular arrhythmias: diagnosis and drug therapy]. Schüpfer C; Gertsch M Praxis (Bern 1994); 1996 May; 85(20):647-54. PubMed ID: 8685556 [TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic properties of Craviten (M-71) in cats and rabbits. Chodera A; Banaszkiewicz W; Glinka B Pol J Pharmacol Pharm; 1980; 32(6):833-40. PubMed ID: 7243680 [TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of arrhythmia in ambulatory practice]. Pomerantsev VP Sov Med; 1990; (8):36-40. PubMed ID: 2274818 [No Abstract] [Full Text] [Related]
16. Arrhythmias and antiarrhythmic drugs. Urthaler F Ala J Med Sci; 1984 Jul; 21(3):275-83. PubMed ID: 6476289 [No Abstract] [Full Text] [Related]
17. Programmed electrical stimulation of the heart to select antiarrhythmic drug treatment in patients with recurrent ventricular arrhythmias. Brugada P; Wellens HJ Eur Heart J; 1987 Mar; 8 Suppl A():91-5. PubMed ID: 3556181 [No Abstract] [Full Text] [Related]
18. [Drug treatment of heart rhythm disorders: the choice of anti-arrhythmia therapy and control of its efficacy]. Golitsyn SP; Sokolov SF Kardiologiia; 1983 Nov; 23(11):5-8. PubMed ID: 6656086 [No Abstract] [Full Text] [Related]
19. [Quantitative evaluation of the efficacy of anti-arrhythmia agents in chronic ventricular arrhythmia]. Leclercq JF; Attuel P; Milosevic D; Coumel P Acta Cardiol; 1979; 34(1):35-50. PubMed ID: 312581 [TBL] [Abstract][Full Text] [Related]